Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis (Q33360047)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

8

object named as

Jawed Fareed

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Sarfraz Ahmad

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Brian Untch

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sylvia Haas

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Debra A Hoppensteadt

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Frank Misselwitz

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Harry L Messmore

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jeanine M Walenga

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

258

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

163-170

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Laboratory tests for heparin-induced thrombocytopenia: a multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia: molecular pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications--a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia and thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2002. A 53-year-old man with a myocardial infarct and thromboses after coronary-artery bypass grafting

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biological basis of immune heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the humoral immune response in heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A diagnostic test for heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of Fc gamma RII in platelet activation by monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of the patient population on the risk for heparin-induced thrombocytopenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of the mechanisms of monoclonal antibody-induced platelet activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15030181

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/B:MCBI.0000012852.60500.30

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33360047&oldid=2195282436"